Concepts (51)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Lactoferrin | 4 | 2008 | 78 | 0.870 |
Why?
|
| Iron | 2 | 2004 | 303 | 0.340 |
Why?
|
| Respiratory Burst | 1 | 2008 | 10 | 0.290 |
Why?
|
| Neutrophils | 1 | 2008 | 401 | 0.240 |
Why?
|
| Homeostasis | 2 | 2004 | 751 | 0.200 |
Why?
|
| Global Burden of Disease | 1 | 2022 | 31 | 0.190 |
Why?
|
| Anti-Infective Agents | 1 | 2004 | 269 | 0.180 |
Why?
|
| Immunity, Innate | 1 | 2002 | 407 | 0.150 |
Why?
|
| Intestinal Mucosa | 1 | 2003 | 815 | 0.140 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 2008 | 69 | 0.070 |
Why?
|
| Secretory Vesicles | 1 | 2008 | 21 | 0.070 |
Why?
|
| Dose-Response Relationship, Immunologic | 1 | 2008 | 109 | 0.070 |
Why?
|
| Peroxidase | 1 | 2008 | 72 | 0.070 |
Why?
|
| NADPH Oxidases | 1 | 2008 | 114 | 0.070 |
Why?
|
| Mice, Knockout | 2 | 2008 | 3968 | 0.070 |
Why?
|
| Phagocytosis | 1 | 2008 | 191 | 0.070 |
Why?
|
| Neoplasms | 1 | 2022 | 3023 | 0.070 |
Why?
|
| Leukocytes | 1 | 2008 | 224 | 0.070 |
Why?
|
| Pseudomonas aeruginosa | 1 | 2008 | 176 | 0.060 |
Why?
|
| Disease Susceptibility | 1 | 2008 | 319 | 0.060 |
Why?
|
| Blotting, Western | 1 | 2008 | 1136 | 0.060 |
Why?
|
| Staphylococcus aureus | 1 | 2008 | 476 | 0.060 |
Why?
|
| Mucous Membrane | 1 | 2004 | 93 | 0.050 |
Why?
|
| Cell Movement | 1 | 2008 | 917 | 0.050 |
Why?
|
| Animals, Suckling | 1 | 2003 | 51 | 0.050 |
Why?
|
| Transferrin | 1 | 2003 | 50 | 0.050 |
Why?
|
| Animals | 4 | 2008 | 36364 | 0.050 |
Why?
|
| Mice, Inbred Strains | 1 | 2003 | 321 | 0.050 |
Why?
|
| Duodenum | 1 | 2003 | 110 | 0.050 |
Why?
|
| Milk | 1 | 2003 | 126 | 0.050 |
Why?
|
| Immunity, Mucosal | 1 | 2002 | 92 | 0.050 |
Why?
|
| Host-Parasite Interactions | 1 | 2002 | 83 | 0.050 |
Why?
|
| Quality-Adjusted Life Years | 1 | 2022 | 129 | 0.050 |
Why?
|
| Milk, Human | 1 | 2004 | 311 | 0.040 |
Why?
|
| Cell Differentiation | 1 | 2008 | 2026 | 0.040 |
Why?
|
| Lung | 1 | 2008 | 1555 | 0.040 |
Why?
|
| Hypersensitivity | 1 | 2002 | 198 | 0.040 |
Why?
|
| Animals, Newborn | 1 | 2003 | 1045 | 0.040 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2002 | 319 | 0.040 |
Why?
|
| Intestines | 1 | 2003 | 613 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 1 | 2008 | 4799 | 0.040 |
Why?
|
| Mice | 2 | 2008 | 18876 | 0.040 |
Why?
|
| Global Health | 1 | 2022 | 619 | 0.030 |
Why?
|
| RNA, Messenger | 1 | 2003 | 2900 | 0.030 |
Why?
|
| Prevalence | 1 | 2022 | 2655 | 0.030 |
Why?
|
| Incidence | 1 | 2022 | 3393 | 0.030 |
Why?
|
| Inflammation | 1 | 2002 | 1595 | 0.030 |
Why?
|
| Risk Factors | 1 | 2022 | 11071 | 0.020 |
Why?
|
| Humans | 3 | 2022 | 133809 | 0.020 |
Why?
|
| Male | 1 | 2003 | 65830 | 0.010 |
Why?
|
| Female | 1 | 2003 | 71587 | 0.010 |
Why?
|